SG11201610283WA - Composition with high content of cyclic dipeptide - Google Patents

Composition with high content of cyclic dipeptide

Info

Publication number
SG11201610283WA
SG11201610283WA SG11201610283WA SG11201610283WA SG11201610283WA SG 11201610283W A SG11201610283W A SG 11201610283WA SG 11201610283W A SG11201610283W A SG 11201610283WA SG 11201610283W A SG11201610283W A SG 11201610283WA SG 11201610283W A SG11201610283W A SG 11201610283WA
Authority
SG
Singapore
Prior art keywords
composition
high content
cyclic dipeptide
dipeptide
cyclic
Prior art date
Application number
SG11201610283WA
Other languages
English (en)
Inventor
Toshihide Suzuki
Kenji Yamamoto
Yoshinori Beppu
Hiroshi Watanabe
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11201610283WA publication Critical patent/SG11201610283WA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SG11201610283WA 2014-06-20 2014-12-17 Composition with high content of cyclic dipeptide SG11201610283WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014127768 2014-06-20
PCT/JP2014/083467 WO2015194070A1 (ja) 2014-06-20 2014-12-17 環状ジペプチド高含有組成物

Publications (1)

Publication Number Publication Date
SG11201610283WA true SG11201610283WA (en) 2017-01-27

Family

ID=54935092

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201610283WA SG11201610283WA (en) 2014-06-20 2014-12-17 Composition with high content of cyclic dipeptide

Country Status (10)

Country Link
US (1) US20170114030A1 (ja)
EP (1) EP3158997A1 (ja)
JP (1) JP6796487B2 (ja)
KR (1) KR20170019461A (ja)
CN (1) CN106455664A (ja)
AU (1) AU2014397560A1 (ja)
HK (1) HK1231330A1 (ja)
SG (1) SG11201610283WA (ja)
TW (1) TW201600529A (ja)
WO (1) WO2015194070A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3012264B1 (en) 2013-06-10 2020-03-18 Suntory Holdings Limited Plant extract containing diketopiperazine and method for producing same
WO2017018404A1 (ja) * 2015-07-27 2017-02-02 サントリーホールディングス株式会社 環状ジペプチド及び甘味料を含有する組成物
WO2017034011A1 (ja) * 2015-08-27 2017-03-02 アサヒグループホールディングス株式会社 腸内有用菌増殖剤
JP6683736B2 (ja) * 2015-12-28 2020-04-22 サントリーホールディングス株式会社 容器詰飲料
WO2017115438A1 (ja) * 2015-12-28 2017-07-06 サントリーホールディングス株式会社 ビールテイスト飲料
WO2017168718A1 (ja) * 2016-03-31 2017-10-05 サントリーホールディングス株式会社 容器詰飲料
WO2017168717A1 (ja) * 2016-03-31 2017-10-05 サントリーホールディングス株式会社 容器詰飲料
TWI729143B (zh) * 2016-05-31 2021-06-01 日商三得利控股股份有限公司 含有咖啡因及環丙胺醯基丙胺酸的組成物、其製造方法、抑制該組成物中咖啡因苦味之方法以及抑制該組成物中環丙胺醯基丙胺酸澀味之方法
WO2018117000A1 (ja) * 2016-12-21 2018-06-28 サントリーホールディングス株式会社 シクロアスパルチルグリシン、グルコース、及びマルトースを含有する飲食品
WO2018117001A1 (ja) * 2016-12-21 2018-06-28 サントリーホールディングス株式会社 シクロアラニルセリンとエタノール及び／又はプロピレングリコールを含有する飲食品

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006261A (en) * 1973-09-28 1977-02-01 Firmenich S.A. Flavoring with mixtures of theobromine and cyclic dipeptides
JP2003252896A (ja) * 2002-02-26 2003-09-10 Toyohashi University Of Technology 高温高圧水を用いた環状ペプチドの合成方法
CN1791420A (zh) * 2003-05-15 2006-06-21 Dmi生物科学公司 T－细胞介导的疾病的治疗
JP2006246795A (ja) * 2005-03-10 2006-09-21 Takai Seisakusho:Kk 機能性を向上させた大豆加工品
JP2011062172A (ja) * 2009-09-18 2011-03-31 Nippon Suisan Kaisha Ltd 食塩及び塩味増強剤を含有する食塩代替調味料
MY178405A (en) 2009-12-25 2020-10-12 Suntory Holdings Ltd Learning motivation improvers
JP5645994B2 (ja) * 2012-06-01 2014-12-24 三井農林株式会社 茶葉由来のタンパク質分解物の製造方法
JP5456876B1 (ja) * 2012-12-25 2014-04-02 ゼライス株式会社 環状ジペプチドの製造方法
EP3012264B1 (en) * 2013-06-10 2020-03-18 Suntory Holdings Limited Plant extract containing diketopiperazine and method for producing same

Also Published As

Publication number Publication date
EP3158997A1 (en) 2017-04-26
WO2015194070A1 (ja) 2015-12-23
CN106455664A (zh) 2017-02-22
US20170114030A1 (en) 2017-04-27
JPWO2015194070A1 (ja) 2017-04-20
AU2014397560A1 (en) 2017-01-05
KR20170019461A (ko) 2017-02-21
TW201600529A (zh) 2016-01-01
JP6796487B2 (ja) 2020-12-09
HK1231330A1 (zh) 2017-12-22

Similar Documents

Publication Publication Date Title
HK1245080A1 (zh) 自然殺傷細胞的方法和組合物
HK1243333A1 (zh) 用於修飾的t細胞的方法和組合物
HK1231330A1 (zh) 高含有環狀二肽的組合物
GB2535253B (en) Compositions and methods
EP3230956A4 (en) Augmentation of stop-motion content
ZA201702794B (en) Cellulose-containing compositions and methods of making same
SG11201704010UA (en) Fibroin-derived protein composition
SG11201610090RA (en) Cyclic dipeptide-containing composition
PL3017708T3 (pl) Kompozycja słodząca
PL3130669T3 (pl) Nowy bakteriofag i zawierająca go kompozycja
IL251703B (en) A pharmaceutical preparation with improved stability
SG11201610978SA (en) Novel sweetening composition
PT3148540T (pt) PROCESSO PARA A PREPARAÇAÞO DE DEPSIPÉPTIDOS CIìCLICOS
SG11201605753VA (en) Nutrition composition
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
SG11201702334SA (en) External preparation composition containing s-flurbiprofen
GB201504683D0 (en) Improvements in or relating to manufacture of packing
HK1247220A1 (zh) 環狀甘丙肽類似物及其用途
IL251236B (en) Preparations containing glycosaminoglycans and proteins and their uses
GB201401706D0 (en) Nanoparticle-insulin and insulin analogue compositions
GB201402915D0 (en) Compositions and methods
GB201404700D0 (en) Novel Composition
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
GB201415759D0 (en) Accelerator compositions and methods